Drug General Information (ID: DDIYIU5WAR)
  Drug Name Chloroquine Drug Info Penicillamine Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antimalarial Agents Antidotes
  Structure

 Mechanism of Chloroquine-Penicillamine Interaction (Severity Level: Moderate)
     Additive immunosuppressive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Chloroquine Penicillamine
      Mechanism Myelosuppressive effects Myelosuppressive effects
      Key Mechanism Factor 1
Factor Name Immunosuppressive effects
Factor Description Immunosuppression is when your immune system is not functioning as it should. The immune system is made up of cells, tissues and organs that help the body fight off infections. If the immune system is suppressed, an infection that your body was able to control may become serious or even fatal.
      Mechanism Description
  • Additive immunosuppressive effects by the combination of Chloroquine and Penicillamine 

Recommended Action
      Management In general, penicillamine and chloroquine or hydroxychloroquine therapy should not be administered concurrently. Caution is advised if these drugs must be used together. Pharmacologic response to penicillamine should be monitored more closely whenever chloroquine is added to or withdrawn from therapy, and the penicillamine dosage adjusted as necessary. Patients should be advised to notify their physician if they experience signs and symptoms of toxicity such as fever, chills, sore throat, unusual bruising or bleeding, hematuria, coughing, wheezing, unexplained shortness of breath, muscle weakness, or visual disturbances.

References
1 Haagsma CJ "Clinically important drug interactions with disease-modifying antirheumatic drugs." Drugs Aging 13 (1998): 281-9. [PMID: 9805209]
2 Product Information. Cuprimine (penicillamine). Merck &amp Co, Inc, West Point, PA.
3 Seideman P, Linstrom B "Pharmacokinetic interactions of pencillamine in rheumatoid arthritis." J Rheumatol 16 (1989): 473-4